IDH1 and central nervous system cancer: Notably, WHO grade IV gliomas showed higher TBRmax and PET volumes as compared with WHO grade III and II lesions, as well as a trend towards a higher TBRmax, although not at a statistically significant level, was observed in IDH wild-type gliomas with respect to IDH-mutant ones in the overall group.